Haemophilus influenzae type b. Epidemiology of invasive diseases, antimicrobial resistance of clinical isolates, and response to a conjugate vaccine in selected risk groups.
Kristensen
K
K
Streptococcus Department, Statens Serum Institut, Copenhagen.
D000818:Animals; D016667:Bacterial Capsules; D004352:Drug Resistance, Microbial; D006192:Haemophilus Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control / Q000628:therapy*; D018073:Haemophilus Vaccines / Q000627:therapeutic use*; D019741:Haemophilus influenzae type b; D006801:Humans; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D012307:Risk Factors; D018074:Vaccines, Conjugate / Q000627:therapeutic use
D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D011135:Polysaccharides, Bacterial; D018074:Vaccines, Conjugate